Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Bakri Balloon Placement Technique

  • Author: Gabor C Mezei, MD, PhD; Chief Editor: Carl V Smith, MD  more...
 
Updated: Jul 06, 2016
 

Approach Considerations

After vaginal delivery

For transvaginal placement following vaginal delivery, the following steps should be considered:

  • Before insertion the balloon, ensure that the bladder is empty by placing a Foley catheter.
  • Inspection of the uterine cavity should be made to ascertain that the uterine cavity is clear of placental fragments.
  • The cervix and vagina should be cleansed with an antiseptic solution, such as povidone iodine.
  • Grasp the cervix with ring forceps. Insert the balloon into the cavity of the uterus under ultrasound guidance, making sure that the entire portion of the balloon passes the cervical canal above the internal cervical os. This can be also achieved by manual insertion of the catheter similar to insertion of an intrauterine pressure catheter.
  • Once the correct placement is confirmed, inflate the balloon with sterile saline using the enclosed syringe. The recommended maximum capacity of the balloon is 500 mL.
  • In order to maximize the effect of tamponade most notable to the lower uterine segment, apply gentle traction to the shaft of the balloon. This can be achieved and maintained by securing the balloon shaft to the patient leg or attaching to a weight, not to exceed 500 grams.
  • Connect the drainage port to a fluid collecting bag to monitor hemostasis.
  • Monitor patient continuously for signs of increased bleeding and uterine cramping.

After cesarean section

At laparotomy following a cesarean section, the following specific steps should be considered:

  • Insert the end of the catheter through the open uterine incision to the cervix and then into the vagina.
  • Close the uterine incision while taking special care not to damage the balloon by the suturing needle.
  • Insufflate the balloon under direct visualization.

This may potentially result in balloon failure secondary to incidental puncture of the balloon by the needle. An alternative approach is to close the uterus first and then insert the balloon from the vagina and inflate it while the surgeon watches from above.

Next

The Tamponade Test

The effectiveness of the intrauterine balloon catheter can be assessed by the “tamponade test” first described by Condous and colleagues.[20] This test is considered positive when control is achieved following inflation of the balloon.[21] Patients with a negative test (ie, persistent bleeding despite the balloon placement) should proceed to more invasive therapeutic approaches such as laparotomy or embolization depending on personnel and facilities.

Previous
Next

Use of Vaginal Pack

The early publications involving the Bakri balloon suggested the use of a vaginal pack to maintain the balloon in the vagina and to provide additional compression of the lower uterine segment. However, no clear evidence suggests the beneficial effect of this additional approach. If a vaginal pack is to be used, then a positive tamponade test needs to be demonstrated prior to placement of the vaginal pack. Otherwise, a danger exists that the pack will obscure any continuing bleeding leading to a delayed diagnosis of ineffective tamponade.

Previous
Next

Use of Antibiotics and Uterotonic Agents

Most experts suggest the use of antibiotics to reduce the risk of iatrogenic infection caused by contamination of the uterine environment by the balloon. However, the effectiveness of antibiotics in this setting has not been studied. Prophylactic (single-dose) administration or for the duration of balloon usage (up to 24 hours) is recommended.

The use of oxytocin or other uterotonics (eg, methylergonovine, prostaglandins) are generally recommended to prevent atony. But again, no clear evidence for this approach exists either

Previous
Next

Combination with Other Techniques

External compression plus internal tamponade (uterine sandwich)

Intrauterine balloon catheters can be used in combination with other surgical interventions to potentially increase effectiveness.

One study evaluating the effectiveness of placing an intrauterine Bakri balloon in conjunction with the B-Lynch uterine compression suture in successfully treating uterine atony.[22] Five cases of cesarean deliveries with persistent bleeding from uterine atony refractory to medical treatment and B-Lynch suture underwent Bakri balloon placement with median volume of 100 mL of fluid inflation. The numbers of cases are very small, but the result is promising.

Uterine vessel ligation plus internal tamponade

Hypogastric artery ligation, O’Leary uterine artery ligation, or bilateral looped uterine vessel sutures (B-LUVS) can be also used in conjunction with intrauterine Bakri balloon placement. No scientific data are available at this moment regarding these techniques, but an evaluation of this combinational technique regarding efficacy and safety is ongoing.[9]

Previous
 
Contributor Information and Disclosures
Author

Gabor C Mezei, MD, PhD Fellow in Maternal-Fetal Medicine, Clinical Instructor, Department of Obstetrics and Gynecology, The Milton S Hershey Medical Center, Pennsylvania State University College of Medicine

Gabor C Mezei, MD, PhD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Hungarian Medical Association of America, Society for Maternal-Fetal Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Serdar H Ural, MD Associate Professor of Obstetrics and Gynecology and Radiology, Director, Division of Maternal-Fetal Medicine, Medical Director, Labor and Delivery Suite, Pennsylvania State University College of Medicine

Serdar H Ural, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, Association of Professors of Gynecology and Obstetrics, AAGL, Society for Maternal-Fetal Medicine

Disclosure: Received honoraria from GSK for speaking and teaching; Received honoraria from J&J for speaking and teaching.

Specialty Editor Board

Jori S Carter, MD, MS Assistant Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine

Jori S Carter, MD, MS is a member of the following medical societies: Alpha Omega Alpha, American College of Obstetricians and Gynecologists, Society of Gynecologic Oncology, Association of Women Surgeons, International Society for Magnetic Resonance in Medicine, American Society of Clinical Oncology

Disclosure: Nothing to disclose.

Chief Editor

Carl V Smith, MD The Distinguished Chris J and Marie A Olson Chair of Obstetrics and Gynecology, Professor, Department of Obstetrics and Gynecology, Senior Associate Dean for Clinical Affairs, University of Nebraska Medical Center

Carl V Smith, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, Association of Professors of Gynecology and Obstetrics, Central Association of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine, Council of University Chairs of Obstetrics and Gynecology, Nebraska Medical Association

Disclosure: Nothing to disclose.

References
  1. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006 Oct. 108(4):1039-47. [Medline].

  2. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006 Apr 1. 367(9516):1066-74. [Medline].

  3. Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum hemorrhage today: ICM/FIGO initiative 2004-2006. Int J Gynaecol Obstet. 2006 Sep. 94(3):243-53. [Medline].

  4. Bakri YN, Amri A, Abdul Jabbar F. Tamponade-balloon for obstetrical bleeding. Int J Gynaecol Obstet. 2001 Aug. 74(2):139-42. [Medline].

  5. Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG. 2009 May. 116(6):748-57. [Medline].

  6. Lo A, St Marie P, Yadav P, Belisle E, Markenson G. The Impact of Bakri Balloon Tamponade on the Rate of Postpartum Hysterectomy for Uterine Atony. J Matern Fetal Neonatal Med. 2016 Jun 30. 1-15. [Medline].

  7. Bakri Postpartum Balloon product literature, Cook Medical Inc. Bloomington, IN, USA. www.cookmedical.com.

  8. BT-Cath [package insert]. Midvale, UT: Utah Medical Products, Inc. 2012. Available at [Full Text].

  9. Bakri YN. Use of intrauterine balloon catheters for control of uterine hemorrhage. UpToDate. 2012. [Full Text].

  10. Aggarwal N. The "tamponade test" in the management of massive postpartum hemorrhage. Obstet Gynecol. 2003 Sep. 102(3):641; author reply 641-2. [Medline].

  11. Vitthala S, Tsoumpou I, Anjum ZK, Aziz NA. Use of Bakri balloon in post-partum haemorrhage: a series of 15 cases. Aust N Z J Obstet Gynaecol. 2009 Apr. 49(2):191-4. [Medline].

  12. Stefanovic V, Grönvall M, Tikkanen M, Tallberg E, Paavonen J. Reply: Bakri balloon tamponade for postpartum hemorrhage. Acta Obstet Gynecol Scand. 2013 Sep. 92(9):1119. [Medline].

  13. Nesbitt A, Rai N, Limbu J, Leslie I, Yoong W. To tamponade or not to tamponade?. Acta Obstet Gynecol Scand. 2013 Sep. 92(9):1118-9. [Medline].

  14. Grönvall M, Tikkanen M, Tallberg E, Paavonen J, Stefanovic V. Use of Bakri balloon tamponade in the treatment of postpartum hemorrhage: a series of 50 cases from a tertiary teaching hospital. Acta Obstet Gynecol Scand. 2013 Apr. 92(4):433-8. [Medline].

  15. Laas E, Bui C, Popowski T, Mbaku OM, Rozenberg P. Trends in the rate of invasive procedures after the addition of the intrauterine tamponade test to a protocol for management of severe postpartum hemorrhage. Am J Obstet Gynecol. 2012 Oct. 207(4):281.e1-7. [Medline].

  16. Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv. 2007 Aug. 62(8):540-7. [Medline].

  17. Dabelea V, Schultze PM, McDuffie RS Jr. Intrauterine balloon tamponade in the management of postpartum hemorrhage. Am J Perinatol. 2007 Jun. 24(6):359-64. [Medline].

  18. Johanson R, Kumar M, Obhrai M, Young P. Management of massive postpartum haemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. BJOG. 2001 Apr. 108(4):420-2. [Medline].

  19. Kaya B, Guralp O, Tuten A, Unal O, Celik MO, Dogan A. Which uterine sparing technique should be used for uterine atony during cesarean section? The Bakri balloon or the B-Lynch suture?. Arch Gynecol Obstet. 2016 Jan 18. [Medline].

  20. Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K. The "tamponade test" in the management of massive postpartum hemorrhage. Obstet Gynecol. 2003 Apr. 101(4):767-72. [Medline].

  21. Georgiou C. Intraluminal pressure readings during the establishment of a positive 'tamponade test' in the management of postpartum haemorrhage. BJOG. 2010 Feb. 117(3):295-303. [Medline].

  22. Nelson WL, O'Brien JM. The uterine sandwich for persistent uterine atony: combining the B-Lynch compression suture and an intrauterine Bakri balloon. Am J Obstet Gynecol. 2007 May. 196(5):e9-10. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.